Previous close | 1.0000 |
Open | 1.0000 |
Bid | 0.2500 |
Ask | 1.3500 |
Strike | 150.00 |
Expiry date | 2024-10-18 |
Day's range | 1.0000 - 1.0000 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.